Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fabien Ricard"'
Autor:
Suneel Kamath, David Tai, Irene Moreno, Hani Babiker, Zhaohui Jin, Changhoon Yoo, Fabien Ricard, Kai Yu Jen, Jim Coward, Jia Liu, Frans Opdam, Michael Millward, Mariano Ponz-Sarvise, Jeffrey Yachnin, Richard Kim, Joon Oh Park, Vivek Subbiah, Alison M. Schram
Publikováno v:
Cancer Research. 83:OT3-24
Background: Oncogenic alterations (gene amplification, mutation, and fusion/rearrangements) of fibroblast growth factor receptor 2 (FGFR2) are rare and occur at varying frequencies across solid tumor types and have become critical therapeutic targets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d437530495cc24438e011cd6285cf5de
https://doi.org/10.1158/1538-7445.sabcs22-ot3-24-01
https://doi.org/10.1158/1538-7445.sabcs22-ot3-24-01
Autor:
Fabien Ricard, Bruce Cheson, Sally Barrington, Judith Trotman, Annette Schmid, Guenther Brueggenwerth, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann, Ron Korn
Publikováno v:
J Nucl Med
Our objective was to provide consensus recommendations from a consortium of academic and industry experts in the field of lymphoma and imaging for consistent application of the Lugano classification. Methods: Consensus was obtained through a series o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713dc68d32528bf41cf72833d913fdf0
https://doi.org/10.2967/jnumed.122.264106
https://doi.org/10.2967/jnumed.122.264106
Autor:
Fabien Ricard, Sally Barrington, Ron Korn, Guenther Brueggenwerth, Judith Trotman, Bruce Cheson, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann, Annette Schmid
Publikováno v:
Journal of Nuclear Medicine. 64:239-243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3c94698f7496e1be09d903abfdaf7e
https://doi.org/10.2967/jnumed.122.264124
https://doi.org/10.2967/jnumed.122.264124
Autor:
Jinshan Shen, Rishikesh Sawant, Rick Blakesley, Kai Yu Jen, Fabien Ricard, Xiaoyan Li, Cassandra Key, Djuro Karanovic
Publikováno v:
Cancer Research. 83:2795-2795
Background/Introduction: Effective therapies for FGFR2-driven cholangiocarcinoma (CCA) and other advanced solid tumors remain unmet medical needs. RLY-4008 is a potent, highly selective and irreversible FGFR2 inhibitor designed to target both primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::090ac104267a506f6dc9a61cf7315de1
https://doi.org/10.1158/1538-7445.am2023-2795
https://doi.org/10.1158/1538-7445.am2023-2795